NR4A2 is a family member of AR (NR3C4), which is known to be activated downstream of the MAPK pathway in cancer [57] and directly interacts with NFκB (specifically the REL subunit), as correctly predicted for NR4A2 [58]. Here, AR is linked to cancer.